XML 41 R31.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Segment Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2017
Segment Information [Abstract] |
Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments |
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿ | Three Months Ended |  | Nine Months Ended
﻿ | September 30, |  | September 30,
﻿ | 2017 |  | 2016 |  | 2017 |  | 2016
﻿Revenues: |  |  |  |  |  |  |  |  |  |  |
﻿Medical devices | $ | 27,029 |  | $ | 28,004 |  | $ | 84,519 |  | $ | 85,067
﻿Preservation services |  | 16,970 |  |  | 17,248 |  |  | 52,357 |  |  | 50,284
﻿Total revenues |  | 43,999 |  |  | 45,252 |  |  | 136,876 |  |  | 135,351
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿Cost of products and preservation services: |  |  |  |  |  |  |  |  |  |  |
﻿Medical devices |  | 6,220 |  |  | 6,598 |  |  | 21,196 |  |  | 21,299
﻿Preservation services |  | 7,917 |  |  | 8,872 |  |  | 23,401 |  |  | 26,348
﻿Total cost of products and preservation services |  | 14,137 |  |  | 15,470 |  |  | 44,597 |  |  | 47,647
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿Gross margin: |  |  |  |  |  |  |  |  |  |  |
﻿Medical devices |  | 20,809 |  |  | 21,406 |  |  | 63,323 |  |  | 63,768
﻿Preservation services |  | 9,053 |  |  | 8,376 |  |  | 28,956 |  |  | 23,936
﻿Total gross margin | $ | 29,862 |  | $ | 29,782 |  | $ | 92,279 |  | $ | 87,704
﻿
Summary Of Net Revenues By Product And Service |
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿ | Three Months Ended |  | Nine Months Ended
﻿ | September 30, |  | September 30,
﻿ | 2017 |  | 2016 |  | 2017 |  | 2016
﻿Products: |  |  |  |  |  |  |  |  |  |  |
﻿BioGlue and BioFoam | $ | 15,730 |  | $ | 15,976 |  | $ | 48,094 |  | $ | 47,479
﻿On-X |  | 8,326 |  |  | 8,890 |  |  | 27,048 |  |  | 25,159
﻿CardioGenesis cardiac laser therapy |  | 1,489 |  |  | 1,653 |  |  | 5,130 |  |  | 5,497
﻿PerClot |  | 886 |  |  | 950 |  |  | 2,641 |  |  | 2,983
﻿PhotoFix |  | 598 |  |  | 535 |  |  | 1,606 |  |  | 1,406
﻿HeRO Graft |  | -- |  |  | -- |  |  | -- |  |  | 2,325
﻿ProCol |  | -- |  |  | -- |  |  | -- |  |  | 218
﻿Total products |  | 27,029 |  |  | 28,004 |  |  | 84,519 |  |  | 85,067
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿Preservation services: |  |  |  |  |  |  |  |  |  |  |
﻿Cardiac tissue |  | 7,932 |  |  | 8,279 |  |  | 23,911 |  |  | 22,255
﻿Vascular tissue |  | 9,038 |  |  | 8,969 |  |  | 28,446 |  |  | 28,029
﻿Total preservation services |  | 16,970 |  |  | 17,248 |  |  | 52,357 |  |  | 50,284
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿Total revenues | $ | 43,999 |  | $ | 45,252 |  | $ | 136,876 |  | $ | 135,351
﻿

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration